Cardiff Oncology

Cardiff Oncology is develops drugs that target cell division for the treatment of leukemias, lymphomas, and solid tumor cancers.

Business Model:

Revenue: $0

Employees: 11-50

Detailed Cardiff Oncology Information

Geographic Data

Cardiff Oncology headquarters map

Address:

City: San Diego

State: California

Zip:

Country: United States

Financial Info

Stage:

post ipo equity

Raised Last:

$15M

Raised Total:

$80M

Metrics

3,659,849Website Global Rank

3,572Website Monthly Traffic

Twitter Followers

Description

Cardiff Oncology is a clinical-stage oncology therapeutics company developing drugs that target cell division for the treatment of leukemias, lymphomas, and solid tumor cancers. It has a broad intellectual property and proprietary technology to measure circulating tumor DNA (ctDNA) in urine and blood to identify and quantify clinically actionable markers for predicting response to cancer therapies. The company offers its PCM technology at its CLIA/CAP-accredited laboratory and plans to continue to vertically integrate its PCM technology with precision cancer therapeutics. Cardiff Oncology (formerly known as Trovagene) was founded in 1999 and is headquartered in San Diego, California.

Contact Phone:

Contact Email:

Cardiff Oncology went public on 7/27/2004 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/27/2004

Ticker Symbol:
CRDF

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/2014 Post-IPO Debt 2 $15M Oxford Finance LLC
Silicon Valley Bank
Oxford Finance LLC
Silicon Valley Bank
6/2018 Post-IPO Equity $18M
3/2012 Post-IPO Equity $6.6M
6/2020 Post-IPO Equity 2 $13.5M Acorn Bioventures
CAM Capital
Acorn Bioventures
CAM Capital
Acorn Bioventures
CAM Capital
Acorn Bioventures
CAM Capital
12/2012 Post-IPO Equity $3.8M
11/2021 Post-IPO Equity 1 $15M Pfizer Breakthrough Growth Initiative
Pfizer Breakthrough Growth Initiative
Pfizer Breakthrough Growth Initiative
Pfizer Breakthrough Growth Initiative
7/2017 Post-IPO Equity $7.1M
4/2019 Post-IPO Equity $1.5M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research